Aveanna Healthcare Holdings Inc.
AVAH · NASDAQ
12/28/2024 | 12/30/2023 | 12/31/2022 | 1/1/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.89 | 0.05 | -0.00 | -0.11 |
| FCF Yield | 2.93% | 3.25% | -41.74% | -2.00% |
| EV / EBITDA | 12.36 | 50.15 | -2.82 | -146.75 |
| Quality | ||||
| ROIC | -20.63% | 0.54% | -45.31% | -1.85% |
| Gross Margin | 31.39% | 31.42% | 30.95% | 32.31% |
| Cash Conversion Ratio | -2.99 | -0.17 | 0.07 | 0.10 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.23% | 4.13% | 6.14% | 6.64% |
| Free Cash Flow Growth | 58.96% | 127.40% | -121.30% | -126.93% |
| Safety | ||||
| Net Debt / EBITDA | 7.57 | 37.15 | -2.54 | -70.62 |
| Interest Coverage | 0.89 | 0.05 | -5.96 | -0.52 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 40.48 | 38.88 | 32.87 | 32.08 |